Storch A - Search Results

1

Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.

Oehme L, Perick M, Beuthien-Baumann B, Wolz M, Storch A, Löhle M, Herting B, Langner J, van den Hoff J, Reichmann H, Kotzerke J. Oehme L, et al. Among authors: storch a. Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1550-9. doi: 10.1007/s00259-011-1819-8. Epub 2011 May 7. Eur J Nucl Med Mol Imaging. 2011. PMID: 21553090 Clinical Trial.

2

Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic culture.

Hamann J, Rommelspacher H, Storch A, Reichmann H, Gille G. Hamann J, et al. Among authors: storch a. J Neurochem. 2006 Aug;98(4):1185-99. doi: 10.1111/j.1471-4159.2006.03940.x. Epub 2006 Jun 19. J Neurochem. 2006. PMID: 16787411 Free article.

3

Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.

Junghanns S, Fuhrmann JT, Simonis G, Oelwein C, Koch R, Strasser RH, Reichmann H, Storch A. Junghanns S, et al. Among authors: storch a. Mov Disord. 2007 Jan 15;22(2):234-8. doi: 10.1002/mds.21225. Mov Disord. 2007. PMID: 17094087 Clinical Trial.

4

[Gene expression profiling of classic mitochondrial disorders. Its value in finding therapeutic strategies].

Mende S, Storch A, Reichmann H. Mende S, et al. Among authors: storch a. Nervenarzt. 2007 Oct;78(10):1155-9. doi: 10.1007/s00115-007-2266-4. Nervenarzt. 2007. PMID: 17458528 Review. German.

5

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H; German Coenzyme Q(10) Study Group. Storch A, et al. Arch Neurol. 2007 Jul;64(7):938-44. doi: 10.1001/archneur.64.7.nct60005. Epub 2007 May 14. Arch Neurol. 2007. PMID: 17502459 Clinical Trial.

6

Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.

Löhle M, Schrempf W, Wolz M, Reichmann H, Storch A. Löhle M, et al. Among authors: storch a. Mov Disord. 2008 Jul 15;23(9):1314-6. doi: 10.1002/mds.22071. Mov Disord. 2008. PMID: 18442126

7

[Parainfectious polyneuropathy and miller-fisher-syndrome in combination with anemia in Mycoplasma pneumoniae infection].

Loewenbrück KF, Pütz V, Schäfer J, Reichmann H, Storch A. Loewenbrück KF, et al. Among authors: storch a. Fortschr Neurol Psychiatr. 2008 Jun;76(6):361-5. doi: 10.1055/s-2008-1038198. Fortschr Neurol Psychiatr. 2008. PMID: 18512187 German.

8

Dystonia associated with hyperintense basal ganglia lesions on T1-weighted brain MRI.

Wolz M, Junghanns S, Löhle M, von Kummer R, Storch A. Wolz M, et al. Among authors: storch a. Mov Disord. 2008 Aug 15;23(11):1618-9. doi: 10.1002/mds.22128. Mov Disord. 2008. PMID: 18581474 No abstract available.

9

Orally disintegrating selegiline for the treatment of Parkinson's disease.

Löhle M, Storch A. Löhle M, et al. Among authors: storch a. Expert Opin Pharmacother. 2008 Nov;9(16):2881-91. doi: 10.1517/14656566.9.16.2881. Expert Opin Pharmacother. 2008. PMID: 18937619

10

Adherence to antiparkinson medication in a multicenter European study.

Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, Cubo E, Martinez-Martin P, Rascol O, Negre-Pages L, Senard A, Schwarz J, Strecker K, Reichmann H, Storch A, Löhle M, Stocchi F, Grosset K. Grosset D, et al. Among authors: storch a. Mov Disord. 2009 Apr 30;24(6):826-32. doi: 10.1002/mds.22112. Mov Disord. 2009. PMID: 19191340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page